Back to REGN
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
15 competitors in Multiple Myeloma
View Full LandscapeDrug Information
Target Indication
Multiple Myeloma
Mechanism of Action
BCMAxCD3 Bispecific
Clinical Trial
NCT03761108Last updated: 12/3/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts